Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Psychiatry
Published in: BMC Psychiatry 1/2007

Open Access 01-12-2007 | Research article

A controlled trial of the Litebook light-emitting diode (LED) light therapy device for treatment of Seasonal Affective Disorder (SAD)

Authors: Paul H Desan, Andrea J Weinstein, Erin E Michalak, Edwin M Tam, Ybe Meesters, Martine J Ruiter, Edward Horn, John Telner, Hani Iskandar, Diane B Boivin, Raymond W Lam

Published in: BMC Psychiatry | Issue 1/2007

Login to get access

Abstract

Background

Recent research has emphasized that the human circadian rhythm system is differentially sensitive to short wavelength light. Light treatment devices using efficient light-emitting diodes (LEDs) whose output is relatively concentrated in short wavelengths may enable a more convenient effective therapy for Seasonal Affective Disorder (SAD).

Methods

The efficacy of a LED light therapy device in the treatment of SAD was tested in a randomized, double-blind, placebo-controlled, multi-center trial. Participants aged 18 to 65 with SAD (DSM-IV major depression with seasonal pattern) were seen at Baseline and Randomization visits separated by 1 week, and after 1, 2, 3 and 4 weeks of treatment. Hamilton Depression Rating Scale scores (SIGH-SAD) were obtained at each visit. Participants with SIGH-SAD of 20 or greater at Baseline and Randomization visits were randomized to active or control treatment: exposure to the Litebook LED treatment device (The Litebook Company Ltd., Alberta, Canada) which delivers 1,350 lux white light (with spectral emission peaks at 464 nm and 564 nm) at a distance of 20 inches or to an inactivated negative ion generator at a distance of 20 inches, for 30 minutes a day upon awakening and prior to 8 A.M.

Results

Of the 26 participants randomized, 23 completed the trial. Mean group SIGH-SAD scores did not differ significantly at randomization. At trial end, the proportions of participants in remission (SIGH-SAD less than 9) were significantly greater (Fisher's exact test), and SIGH-SAD scores, as percent individual score at randomization, were significantly lower (t-test), with active treatment than with control, both in an intent-to-treat analysis and an observed cases analysis. A longitudinal repeated measures ANOVA analysis of SIGH-SAD scores also indicated a significant interaction of time and treatment, showing superiority of the Litebook over the placebo condition.

Conclusion

The results of this pilot study support the hypothesis that light therapy with the Litebook is an effective treatment for SAD.

Trial registration

Clinicaltrials.gov: NCT00139997
Appendix
Available only for authorised users
Literature
1.
Rosenthal NE, Sack DA, Gillin JC, Lewy AJ, Goodwin FK, Davenport Y, Mueller PS, Newsome DA, Wehr TA: Seasonal affective disorder. A description of the syndrome and preliminary findings with light therapy. Arch Gen Psychiatry. 1984, 41: 72-80.CrossRefPubMed
2.
Lam RW, Levitt AJ, (Eds): Canadian Consensus Guidelines for the Treatment of Seasonal Affective Disorder. 1999, Clinical and Academic Publishing
3.
Terman M, Terman JS, Ross DC: A controlled trial of timed bright light and negative air ionization for treatment of winter depression. Arch Gen Psychiatry. 1998, 55: 875-882. 10.1001/archpsyc.55.10.875.CrossRefPubMed
4.
Eastman CI, Young MA, Fogg LF, Liu L, Meaden PM: Bright light treatment of winter depression: a placebo-controlled trial. Arch Gen Psychiatry. 1998, 55: 883-889. 10.1001/archpsyc.55.10.883.CrossRefPubMed
5.
Lam RW, Levitt AJ, Levitan RD, Enns MW, Morehouse R, Michalak EE, Tam EM: The CAN-SAD study: a randomized controlled trial of the effectiveness of light therapy and fluoxetine in patients with winter seasonal affective disorder. Am J Psychiatry. 2006, 163: 805-812. 10.1176/appi.ajp.163.5.805.CrossRefPubMed
6.
Terman M, Terman JS, Quitkin FM, McGrath PJ, Stewart JW, Rafferty B: Light therapy for seasonal affective disorder. A review of efficacy. Neuropsychopharmacology. 1989, 2: 1-22. 10.1016/0893-133X(89)90002-X.CrossRefPubMed
7.
Lee TMC, Blashko CA, Janzen HL, Paterson JG, Chan CC: Pathophysiological mechanism of seasonal affective disorder. J Affect Disord. 1997, 1: 25-38. 10.1016/S0165-0327(97)00076-1.CrossRef
8.
Golden RN, Gaynes BN, Ekstrom RD, Hamer RM, Jacobsen FM, Suppes T, Wisner KL, Nemeroff CB: The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. Am J Psychiatry. 2005, 162: 656-662. 10.1176/appi.ajp.162.4.656.CrossRefPubMed
9.
Brainard GC, Hanifin JP, Greeson JM, Byrne B, Glickman G, Gerner E, Rollag MD: Action spectrum for melatonin regulation in humans: evidence for a novel circadian photoreceptor. J Neurosci. 2001, 21: 6405-6412.PubMed
10.
Lockley SW, Brainard GC, Czeisler CA: High sensitivity of the human circadian melatonin rhythm to resetting by short wavelength light. J Clin Endocrinol Metab. 2003, 88: 4502-4505. 10.1210/jc.2003-030570.CrossRefPubMed
11.
Thapan K, Arendt J, Skene DJ: An action spectrum for melatonin suppression: evidence for a novel non-rod, non-cone photoreceptor system in humans. J of Physiology. 2001, 535: 261-267. 10.1111/j.1469-7793.2001.t01-1-00261.x.CrossRef
12.
Magnusson A, Boivin DB: Seasonal affective disorders: An Overview. Chronobiol Int. 2003, 20: 189-207. 10.1081/CBI-120019310.CrossRefPubMed
13.
Glickman G, Byrne B, Pineda C, Hauck WW, Brainard GC: Light therapy for seasonal affective disorder with blue narrow-band light-emitting diodes (LEDs). Biol Psychiatry. 2005, 20: 1-6.
14.
Terman M, Terman JS: Treatment of seasonal affective disorder with a high-output negative ionizer. J of Alternative & Complementary Med. 1995, 1: 87-92. 10.1089/acm.1995.1.87.CrossRef
15.
Hamilton M: Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967, 6: 278-296.CrossRefPubMed
16.
Williams JB, Link MJ, Rosenthal NE, Amira L, Terman M: Structured Interview Guide for the Hamilton Depression Rating Scale – Seasonal Affective Disorder Version (SIGH-SAD). 1994, New York: New York Psychiatric Institute
17.
18.
APA: American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders. 1994, Washington: American Psychiatric Press, 4
19.
First MB, Spitzer RL, Gibbon M, Williams JB: Structured Clinical Interview for DSM-IV Axis I Disorders. 1996, New York: New York State Psychiatric Institute
20.
Horne JA, Ostberg O: A self-assessment questionnaire to determine morningness-eveningness in human circadian rhythms. Int J Chronobiol. 1976, 4: 97-110.PubMed
21.
Borkovec TD, Nau SD: Credibility of analogue therapy rationales. J Behav Ther Exp Psychiatry. 1972, 3: 257-260. 10.1016/0005-7916(72)90045-6.CrossRef
22.
International Commission on NonIonizing radiation Protection: Guidelines on limits to exposure to broad-band incoherent optical radiation (0.38 to 3 μm). Health Physics. 1997, 73: 539-597.
23.
American Conference of Governmental Industrial Hygienists: Documentation of the Threshold Limit Values and Biological Exposure Indices for 1998. 1998, Cincinnati: American Conference of Governmental Industrial Hygienists
24.
American National Standards Institute and Illuminating Engineering Society of North America: Recommended Practice for Photobiological Safety for Lamps and Lamp Systems – General Requirements (RP 27.1). 1996, New York: Illuminating Engineering Society of North America
25.
Bauer MS, Kurtz JW, Rubin LB, Marcus JG: Mood and behavioral effects of four-week light treatment in winter depressives and controls. J Psychiatr Res. 1994, 28: 135-145. 10.1016/0022-3956(94)90025-6.CrossRefPubMed
26.
Levitt AJ, Levitan R: Length of light treatment trial: does it influence outcome?. Chronobiol Int. 2003, 20: 1213-1215. 10.1081/CBI-120026504.CrossRef
27.
Brainard GC, Lewy AJ, Menaker M, Fredrickson RH, Miller LS, Weleber RG, Cassone V, Hudson D: Dose-response relationship between light irradiance and the suppression of plasma melatonin in human volunteers. Brain Res. 1988, 454: 212-218. 10.1016/0006-8993(88)90820-7.CrossRefPubMed
28.
Lewy AJ, Sack RL, Singer CM: The phase shift hypothesis for bright light's therapeutic mechanism of action: theoretical considerations and experimental evidence. Psychopharmacol Bull. 1987, 23: 349-353.PubMed
29.
Terman JS, Terman M, Lo E, Cooper TB: Circadian time of morning light administration and therapeutic response in winter depression. Arch Gen Psychiatry. 2001, 58: 69-75. 10.1001/archpsyc.58.1.69.CrossRefPubMed
30.
Murray G, Michalak EE, Levitt AJ, Levitan RD, Enns MW, Morehouse R, Lam RW: Therapeutic mechanism in seasonal affective disorder: do fluoxetine and light operate through phase advancing circadian phase?. Chronobiol Int. 2005, 22: 937-943. 10.1080/07420520500263292.CrossRefPubMed
31.
Lewy AJ, Lefler BJ, Hasler BP, et al: Plasma DLMO zeitgeber time: the therapeutic window for phase-delayed winter depressives treated with melatonin. Chronobiol Int. 2003, 20: 1215-1217. 10.1081/CBI-120024215.CrossRef
32.
Gallin PF, Terman M, Reme CE, Rafferty B, Terman JS, Burde RM: Ophthalmological examination of patients with seasonal affective disorder, before and after bright light therapy. Am J Ophthalmol. 1995, 119: 202-210.CrossRefPubMed
Metadata
Title
A controlled trial of the Litebook light-emitting diode (LED) light therapy device for treatment of Seasonal Affective Disorder (SAD)
Authors
Paul H Desan
Andrea J Weinstein
Erin E Michalak
Edwin M Tam
Ybe Meesters
Martine J Ruiter
Edward Horn
John Telner
Hani Iskandar
Diane B Boivin
Raymond W Lam
Publication date
01-12-2007
Publisher
BioMed Central
Published in
BMC Psychiatry / Issue 1/2007
Electronic ISSN: 1471-244X
DOI
https://doi.org/10.1186/1471-244X-7-38

Other articles of this Issue 1/2007

BMC Psychiatry 1/2007 Go to the issue

Research article

Axis I and II disorders as long-term predictors of mental distress: a six-year prospective follow-up of substance-dependent patients

Research article

Auditory target processing in methadone substituted opiate addicts: The effect of nicotine in controls

Research article

Comparative acute efficacy and tolerability of OROS and immediate release formulations of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder

Research article

Victimization and PTSD-like states in an Icelandic youth probability sample

Research article

The assessment of depression awareness and help-seeking behaviour: experiences with the International Depression Literacy Survey

Research article

Greater incidence of depression with hypnotic use than with placebo